A new RV-PA conduit with a natural valve made of bovine jugular vein.
A new RV-PA conduit with a natural valve was developed using bovine jugular vein. To maintain the natural, mechanical properties of the veins, a hydrophilic cross-linking reagent, a glycerol polyglycidyl ether polyepoxy compound (PC) was used. The treatment has already been proven in the field of vascular grafts to be able to reduce antigenicity, biodegradability, and degenerative changes such as calcification, to induce antithrombogenicity with hydrogenicity, and to improve affinity to host cells. Bovine jugular veins were cross-linked with the reagent and were implanted as a conduit into the RV-PA position in six dogs. The main PA was ligated after implantation. One animal died due to bleeding 2 days after implantation; the other animals were healthy and allowed to survive until they were sacrificed. The graft was very soft and as pliable as native tissue, and was as strong as a heart valve. Post-operative catheterization and angiography showed adequate function of the valve. Macroscopic and microscopic observations revealed the antithrombogenicity of the graft in this animal study. These results indicated that this newly developed biologic valved conduit has a high probability of overcoming many problems observed in existing RV-PA conduits.
Ichikawa
Y
Y
First Department of Surgery, Yokohama City University School of Medicine, Japan.
D000792:Angiography; D000818:Animals; D001696:Biomechanical Phenomena; D001705:Bioprosthesis; D006328:Cardiac Catheterization; D002417:Cattle; D004285:Dogs; D005069:Evaluation Studies as Topic; D006350:Heart Valve Prosthesis; D006352:Heart Ventricles / Q000601:surgery; D007601:Jugular Veins / Q000033:anatomy & histology / Q000502:physiology; D011651:Pulmonary Artery / Q000601:surgery; D013927:Thrombosis / Q000517:prevention & control